As of 2026-09-19, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 12.8x | 8.2x |
| Forward P/E multiples | 11.4x - 15.8x | 14.2x |
| Fair Price | (6.53) - (7.50) | (6.44) |
| Upside | -212.5% - -229.1% | -210.9% |
| Date | EV/EBITDA |